A detailed history of Tritonpoint Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Tritonpoint Wealth, LLC holds 16,258 shares of NVO stock, worth $1.67 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
16,258
Previous 16,895 3.77%
Holding current value
$1.67 Million
Previous $2.41 Billion 18.59%
% of portfolio
0.18%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$119.07 - $145.42 $75,847 - $92,632
-637 Reduced 3.77%
16,258 $1.96 Billion
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $24,296 - $29,088
-198 Reduced 1.16%
16,895 $2.41 Billion
Q1 2024

Apr 25, 2024

SELL
$102.11 - $135.92 $251,292 - $334,499
-2,461 Reduced 12.59%
17,093 $1.88 Billion
Q4 2023

Jan 24, 2024

BUY
$87.78 - $105.45 $1.72 Million - $2.06 Million
19,554 New
19,554 $2.02 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tritonpoint Wealth, LLC Portfolio

Follow Tritonpoint Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tritonpoint Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tritonpoint Wealth, LLC with notifications on news.